Tak Takvorian - Concepedia

Author

Tak Takvorian

Dana-Farber Cancer Institute

Also Known As

T Takvorian, T. Takvorian, TAK TAKVORIAN, Tak Takvorian

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Massachusetts General Hospital Harvard University Brigham and Women's Hospital University of Rochester

About

Tak Takvorian is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Health Sciences	10	11	1.2K
3	Immunology	10	10	771
4	Cellular Therapies	2	2	144
5	Hepatology	1	1	73

Tak Takvorian

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma Arnold S. Freedman, Donna Neuberg, Peter Mauch, Blood	1999	348
Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis Tak Takvorian, George P. Canellos, Jerome Ritz, New England Journal of Medicine ImmunologyPathologyAutologous Bone MarrowDisease-free SurvivalImmunotherapy	1987	267
Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Richard M. Stone, Donna Neuberg, RJ Soiffer, Journal of Clinical Oncology	1994	258
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma Jeremy S. Abramson, Matthew D. Hellmann, Jeffrey A. Barnes, Cancer	2010	231
Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. William D. Kaplan, Tak Takvorian, James H. Morris, PubMed Brain Scan ResultsOncologic ImagingPet-mriHigh-grade GliomasBrain Lesion	1987	225
Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. AS Freedman, Tak Takvorian, KC Anderson, Journal of Clinical Oncology ImmunologyPathologyImmunotherapyHematological MalignancyBone Marrow Failure	1990	166
Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. William D. Kaplan, M S Jochelson, Terence S. Herman, Journal of Clinical Oncology Oncologic ImagingResidual Tumor ViabilityPathologyMetronomic ChemotherapyDiffuse Large-cell Lymphoma	1990	163
Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma AS Freedman, Jerome Ritz, Donna Neuberg, Blood	1991	162
Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. Robert J. Soiffer, Christine Murray, Peter Mauch, Journal of Clinical Oncology	1992	141
ANTI-B1 MONOCLONAL ANTIBODY AND COMPLEMENT TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED B-CELL NON-HODGKIN'S LYMPHOMA LeeM. Nadler, Leslie E. Botnick, Robert W. Finberg, The Lancet Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationImmunology	1984	134

Page 1